Randomized Controlled Trial
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 21, 2014; 20(31): 11000-11011
Published online Aug 21, 2014. doi: 10.3748/wjg.v20.i31.11000
Table 5 Results of the secondary outcome measures (n = 85) (mean ± SD)
Outcome measuresGroupBaselinePost-treatmentChanges from baseline to post-treatmentP value
IBDQTreatment157.67 ± 30.43182.23 ± 33.07b24.56 ± 34.150.017
Control157.36 ± 33.19167.29 ± 29.85b9.93 ± 19.13
HGBTreatment118.05 ± 17.79123.14 ± 20.87a5.09 ± 14.450.029
(g/L)Control124.79 ± 20.70123.86 ± 21.23-0.93 ± 10.07
ESRTreatment21.80 ± 16.8617.85 ± 14.14-3.77 ± 13.000.163
(mm/h)Control24.64 ± 22.2824.41 ± 22.10-0.21 ± 10.12
CRPTreatment18.52 ± 24.358.71 ± 8.94b-8.67 ± 20.040.008
(mg/L)Control12.32 ± 13.4313.60 ± 14.811.16 ± 12.11
CDEISTreatment9.92 ± 8.947.64 ± 6.84-2.28 ± 5.520.380
Control6.15 ± 3.905.54 ± 4.79-0.60 ± 4.75
HSTreatment11.2 ± 1.479.00 ± 2.11b-2.2 ± 2.210.029
Control11.07 ± 1.4410.53 ± 2.13-0.53 ± 1.73